February 13, 2024 Comments Off on New patent expiration for Duchesnay drug OSPHENA Posted in: Uncategorized
Annual Drug Patent Expirations for OSPHENA Osphena is a drug marketed by Duchesnay and is included in one NDA. It is available from two suppliers. There are seven patents protecting…
The post New patent expiration for Duchesnay drug OSPHENA appeared fi…
February 13, 2024 Comments Off on New patent for Ocuphire drug RYZUMVI Posted in: Patent Added Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
